关注
Siddharth S. Kesharwani, MS (NIPER-Mohali), Ph.D.
Siddharth S. Kesharwani, MS (NIPER-Mohali), Ph.D.
Sanofi US
在 sanofi.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer
V Jain, H Kumar, HV Anod, P Chand, NV Gupta, S Dey, SS Kesharwani
Journal of Controlled Release 326, 628-647, 2020
1952020
Multifunctional approaches utilizing polymeric micelles to circumvent multidrug resistant tumors
SS Kesharwani, S Kaur, H Tummala, AT Sangamwar
Colloids and Surfaces B: Biointerfaces 173, 581-590, 2019
712019
Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin
S Kumar, SS Kesharwani, H Mathur, M Tyagi, GJ Bhat, H Tummala
European Journal of Pharmaceutical Sciences 82, 86-96, 2016
662016
Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer
Rakesh Dachineni , D. Ramesh Kumar Eduardo Callegari, Siddharth S ...
International Journal of Oncology, 2017
622017
Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route
P Muley, S Kumar, F El Kourati, SS Kesharwani, H Tummala
International journal of pharmaceutics 500 (1-2), 32-41, 2016
622016
Site-directed non-covalent polymer-drug complexes for inflammatory bowel disease (IBD): formulation development, characterization and pharmacological evaluation
SS Kesharwani, R Ahmad, MA Bakkari, MKS Rajput, R Dachineni, ...
Journal of Controlled Release 290, 165-179, 2018
582018
Dendritic cell-targeted nanovaccine delivery system prepared with an immune-active polymer
MKS Rajput, SS Kesharwani, S Kumar, P Muley, S Narisetty, H Tummala
ACS applied materials & interfaces 10 (33), 27589-27602, 2018
522018
The flavonoid metabolite 2, 4, 6-trihydroxybenzoic acid is a CDK inhibitor and an anti-proliferative agent: A potential role in cancer prevention
R Sankaranarayanan, CK Valiveti, DR Kumar, SS Kesharwani, T Seefeldt, ...
Cancers 11 (3), 427, 2019
482019
Overcoming multiple drug resistance in cancer using polymeric micelles
SS Kesharwani, S Kaur, H Tummala, AT Sangamwar
Expert opinion on drug delivery 15 (11), 1127-1142, 2018
472018
Pathogen-mimicking vaccine delivery system designed with a bioactive polymer (inulin acetate) for robust humoral and cellular immune responses
Hemachand Tummala, Sunny Kumar, Siddharth S. Kesharwani, Bhimanna Kuppast ...
Journal of Controlled Release, 2017
472017
Discovery of inulin acetate as a novel immune-active polymer and vaccine adjuvant: synthesis, material characterization, and biological evaluation as a toll-like receptor-4 agonist
S Kumar, SS Kesharwani, B Kuppast, M Rajput, MA Bakkari, H Tummala
Journal of Materials Chemistry B 4 (48), 7950-7960, 2016
392016
Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines
P Chand, H Kumar, N Badduri, NV Gupta, VG Bettada, ...
Colloids and Surfaces B: Biointerfaces 199, 111535, 2021
342021
An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin
SS Kesharwani, V Jain, S Dey, S Sharma, P Mallya, VA Kumar
Journal of Drug Delivery Science and Technology 60, 102021, 2020
302020
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
H Kumar, NV Gupta, R Jain, SRV Madhunapantula, CS Babu, ...
Journal of Advanced Research 54, 271-292, 2023
282023
Nobiletin as a Molecule for Formulation Development: An Overview of Advanced Formulation and Nanotechnology-Based Strategies of Nobiletin
Siddharth S. Kesharwani, Pooja Mallya, Vadikari Arun Kumar, Vikas Jain ...
AAPS PharmSciTech 21, 2020
262020
Hydrophobically modified inulin-based micelles: Transport mechanisms and drug delivery applications for breast cancer
SS Kesharwani, R Dachineni, GJ Bhat, H Tummala
Journal of Drug Delivery Science and Technology 54, 101254, 2019
212019
Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations
SS Kesharwani, PP Nandekar, P Pragyan, V Rathod, AT Sangamwar
Journal of Molecular Recognition 29 (8), 370-390, 2016
202016
Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations
P Pragyan, SS Kesharwani, PP Nandekar, V Rathod, AT Sangamwar
Molecular diversity 18 (4), 865-878, 2014
202014
Formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of zerumbone
SS Kesharwani, GJ Bhat
Medicina 56 (11), 557, 2020
152020
Comparative proteomics among cytochrome p450 family 1 for differential substrate specificity
SS Kesharwani, PP Nandekar, P Pragyan, AT Sangamwar
The Protein Journal 33 (6), 536-548, 2014
122014
系统目前无法执行此操作,请稍后再试。
文章 1–20